SCHEMBL6110482

SCHEMBL6110482

CC([O])N1CCN(CCO)CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.44
CHRM1 P11229 1/20 0.44
ALDH1A1 P00352 6/20 0.43
KDM4E B2RXH2 1/20 0.43
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
HTT P42858 2/20 0.41
LMNA P02545 1/20 0.41
OPRD1 P41143 1/20 0.38
CYP2C19 P33261 2/20 0.37
CYP2D6 P10635 1/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
HPGD P15428 3/20 0.37
HSD17B10 Q99714 3/20 0.37
MEN1 O00255 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C9 P11712 1/20 0.36
HSD11B1 P28845 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL436938 0.82 ALDH1A1 (0.46) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL4398417 0.80 DRD2 (0.38) POLBKMT2AOPRD1MEN1
SCHEMBL6026483 0.80 KMT2A (0.47) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL27732130 0.79 ALDH1A1 (0.43) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL11312006 0.78 ALDH1A1 (0.43) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL6026163 0.78 ALDH1A1 (0.43) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL4656852 0.78 KMT2A (0.46) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL2316273 0.78 ALDH1A1 (0.43) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL26022336 0.78 KMT2A (0.46) CHRM2CHRM1ALDH1A1KDM4EPOLB
SCHEMBL29111135 0.78 CHRM2 (0.44) CHRM2CHRM1ALDH1A1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006066183-A2 NOVEL SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS AXYS PHARMACEUTICALS, INC. (US) 2006-06-22 WO claimed
WO-2006066183-A2 NOVEL SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS AXYS PHARMACEUTICALS, INC. (US) 2006-06-22 WO disclosed
WO-2005118584-A2 SAFRAMYCIN ANALOGS AS THERAPEUTIC AGENTS IN THE TREATMENT OF CANCER AXYS PHARMACEUTICALS, INC. (US) 2005-12-15 WO disclosed